276 related articles for article (PubMed ID: 33304472)
1. EGFR-rich extracellular vesicles derived from highly metastatic nasopharyngeal carcinoma cells accelerate tumour metastasis through PI3K/AKT pathway-suppressed ROS.
Li F; Zhao X; Sun R; Ou J; Huang J; Yang N; Xu T; Li J; He X; Li C; Yang M; Zhang Q
J Extracell Vesicles; 2020 Oct; 10(1):e12003. PubMed ID: 33304472
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived extracellular vesicles inhibit ferroptosis and promote distant metastasis of nasopharyngeal carcinoma by upregulating ITGB3.
Li F; Xu T; Chen P; Sun R; Li C; Zhao X; Ou J; Li J; Liu T; Zeng M; Zheng W; Lin Y; Yang L; Li Z; Chen H; Zhang Q
Int J Biol Sci; 2022; 18(15):5858-5872. PubMed ID: 36263165
[TBL] [Abstract][Full Text] [Related]
3. Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS.
He F; Wei L; Luo W; Liao Z; Li B; Zhou X; Xiao X; You J; Chen Y; Zheng S; Li P; Murata M; Huang G; Zhang Z
Oncotarget; 2016 Jun; 7(24):37000-37012. PubMed ID: 27203742
[TBL] [Abstract][Full Text] [Related]
4. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
[TBL] [Abstract][Full Text] [Related]
5. ADAM22 acts as a novel predictive biomarker for unfavorable prognosis and facilitates metastasis via PI3K/AKT signaling pathway in nasopharyngeal carcinoma.
Xu K; Jiang P; Chen Z; Gu X; Zhang T
Pathol Res Pract; 2024 Apr; 256():155264. PubMed ID: 38518731
[TBL] [Abstract][Full Text] [Related]
6. EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2.
Chen S; Youhong T; Tan Y; He Y; Ban Y; Cai J; Li X; Xiong W; Zeng Z; Li G; Yi M; Liu W; Xiang B
Carcinogenesis; 2020 Jul; 41(6):723-733. PubMed ID: 31665243
[TBL] [Abstract][Full Text] [Related]
7. NOTCH2 negatively regulates metastasis and epithelial-Mesenchymal transition via TRAF6/AKT in nasopharyngeal carcinoma.
Zou Y; Yang R; Huang ML; Kong YG; Sheng JF; Tao ZZ; Gao L; Chen SM
J Exp Clin Cancer Res; 2019 Nov; 38(1):456. PubMed ID: 31699119
[TBL] [Abstract][Full Text] [Related]
8. The important role of the receptor for activated C kinase 1 (RACK1) in nasopharyngeal carcinoma progression.
Peng H; Gong PG; Li JB; Cai LM; Yang L; Liu YY; Yao KT; Li X
J Transl Med; 2016 May; 14(1):131. PubMed ID: 27170279
[TBL] [Abstract][Full Text] [Related]
9. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.
Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W
Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
Huang Q; Hou S; Zhu X; Liu S
World J Surg Oncol; 2020 Feb; 18(1):29. PubMed ID: 32013999
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
Yang Y; Li Q; Guo L
Mol Med Rep; 2018 Jun; 17(6):8244-8252. PubMed ID: 29693120
[TBL] [Abstract][Full Text] [Related]
12. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
Wang B; Gu Q; Li J
Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
[TBL] [Abstract][Full Text] [Related]
13. FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway.
Xie X; Xiong G; Chen W; Fu H; Li M; Cui X
Biochem Cell Biol; 2020 Dec; 98(6):653-660. PubMed ID: 32459973
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients.
Kallergi G; Agelaki S; Kalykaki A; Stournaras C; Mavroudis D; Georgoulias V
Breast Cancer Res; 2008; 10(5):R80. PubMed ID: 18822183
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis.
Bao YN; Cao X; Luo DH; Sun R; Peng LX; Wang L; Yan YP; Zheng LS; Xie P; Cao Y; Liang YY; Zheng FJ; Huang BJ; Xiang YQ; Lv X; Chen QY; Chen MY; Huang PY; Guo L; Mai HQ; Guo X; Zeng YX; Qian CN
Cell Cycle; 2014; 13(12):1958-69. PubMed ID: 24763226
[TBL] [Abstract][Full Text] [Related]
16. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7/EGFR/AKT axis.
Lu C; Zhao Y; Wang J; Shi W; Dong F; Xin Y; Zhao X; Liu C
Mol Med; 2021 Jul; 27(1):78. PubMed ID: 34294040
[TBL] [Abstract][Full Text] [Related]
18. MiR196a-5p in extracellular vesicles released from human nasopharyngeal carcinoma enhance the phagocytosis and secretion of microglia by targeting ROCK1.
Chen P; Liu R; Yu Z; Cui G; Zong W; Wang M; Xie M; Qu W; Wang W; Luo X
Exp Cell Res; 2022 Feb; 411(2):112988. PubMed ID: 34951996
[TBL] [Abstract][Full Text] [Related]
19. The independent, unfavorable prognostic factors endothelin A receptor and chemokine receptor 4 have a close relationship in promoting the motility of nasopharyngeal carcinoma cells via the activation of AKT and MAPK pathways.
Luo DH; Chen QY; Liu H; Xu LH; Zhang HZ; Zhang L; Tang LQ; Mo HY; Huang PY; Guo X; Mai HQ
J Transl Med; 2013 Aug; 11():203. PubMed ID: 23987636
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis.
Hwang CF; Shiu LY; Su LJ; Yu-Fang Yin ; Wang WS; Huang SC; Chiu TJ; Huang CC; Zhen YY; Tsai HT; Fang FM; Huang TL; Chen CH
PLoS One; 2013; 8(12):e84218. PubMed ID: 24386352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
